Exploring gender differences among treatment-seekers who use opioids versus alcohol and other drugs

References

• Alderks, C. 2017. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003–2015 (Update). Rockvillle, MD.
   Google Scholar
• American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, ed. 4th Text Revision., Washington, DC: American Psychiatric Association.
   Google Scholar
• Back, S. E., R. L. Payne, A. N. Simpson, and K. T. Brady. 2010. Gender and prescription opioids: findings from the national survey on drug use and health. Addictive Behaviors 35 (11):1001–07. doi:10.1016/j.addbeh.2010.06.018.
   PubMed Web of Science ®Google Scholar
• Back, S. E., R. L. Payne, A. H. Wahlquist, R. E. Carter, Z. Stroud, L. Haynes, M. Hillhouse, K. T. Brady, and W. Ling. 2011. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. American Journal of Drug and Alcohol Abuse 37 (5):313–23. doi:10.3109/00952990.2011.596982.
   PubMed Web of Science ®Google Scholar
• Bawor, M., B. B. Dennis, M. Varenbut, J. Daiter, D. C. Marsh, C. Plater, A. Worster, Steiner M, Anglin R, Pare G, Desai D, et al. 2015. Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biology of Sex Differences 6:21. doi:10.1186/s13293-015-0038-6.
   PubMed Web of Science ®Google Scholar
• Brands, B., J. Blake, D. C. Marsh, B. Sproule, R. Jeyapalan, and S. Li. 2017. The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Diseases 27 (3):37–48. doi:10.1080/10550880802122620.
   Web of Science ®Google Scholar
• Campbell, A. N. C., C. Barbosa-Leiker, M. Hatch-Maillette, S. E. Mennenga, M. Pavlicova, J. Scodes, T. Saraiya, Mitchell SG, Rotrosen J, Novo P, Nunes EV. et al. 2018. Brief report: gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial. The American Journal on Addictions 27 (6):465–70. doi:10.1111/ajad.12784.
   PubMed Web of Science ®Google Scholar
• Campbell, A. N. C., E. V. Nunes, A. G. Matthews, M. Stitzer, G. M. Miele, D. Polsky, E. Turrigiano, Walters S, McClure EA, Kyle TL, Wahle A . et al. 2014. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. American Journal of Psychiatry 171 (6):683–90. doi:10.1176/aapi.ajp.2014.13081055.
   PubMed Web of Science ®Google Scholar
• Campbell, A. N. C., E. V. Nunes, G. M. Miele, A. Matthews, D. Polsky, U. E. Ghitza, E. Turrigiano, Bailey, G.L., VanVeldhuisen, P., Chapdelaine, R. et al. 2012. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA clinical trials network. Contemporary Clinical Trials 33 (2):386–95. doi:10.1016/j.cct.2011.11.001.
   PubMed Web of Science ®Google Scholar
• Campbell, A. N. C., and M. Wolff. 2017. Women and substance use disorders. In Women’s mental health across the lifespan, ed. K. Kendall-Tackett and L. M. Ruglass, 195–218. New York, NY: Routledge.
   Google Scholar
• Center for Disease Control and Prevention. 2015. Today’s heroin epidemic. Accessed July 22, 2019. https://www.cdc.gov/vitalsigns/heroin/index.html
   Google Scholar
• Center for Disease Control and Prevention. 2017. National vital statistics system, mortality. Atlanta, GA. Accessed July 22, 2019. https://wonder.cdc.gov.
   Google Scholar
• Cicero, T. J., M. S. Ellis, H. L. Surratt, and S. P. Kurtz. 2014. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry (Chicago, Ill.) 71 (7):821–26. doi:10.1001/jamapsychiatry.2014.366.
   PubMed Web of Science ®Google Scholar
• Cunningham, J. L., J. R. Craner, M. M. Evans, and W. M. Hooten. 2017. Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program. Journal of Pain Research 10:311–17. doi:10.2147/JPR.S123487.
   PubMed Web of Science ®Google Scholar
• Darnall, B. D., B. R. Stacey, and R. Chou. 2012. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Medicine 13:1181–211. doi:10.1111/j.1526-4637.2012.01467.x.
   PubMed Web of Science ®Google Scholar
• Derogatis, L. R. 2001. Brief symptom inventory (BSI)-18. Administration, scoring and procedures manual. Minneapolis. NCS Pearson, Inc.
   Google Scholar
• The EuroQol Group. 1990. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands) 16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Green, T. C., J. M. Grimes Serrano, A. Licari, S. H. Budman, and S. F. Butler. 2009. Women who abuse prescription opioids: findings from the addiction severity index-multimedia version connect prescription opioid database. Drug and Alcohol Dependence 103:65–73. doi:10.1016/j.drugalcdep.2009.03.014.
   PubMed Web of Science ®Google Scholar
• Green, T. C., M. R. Polen, D. M. Dickinson, F. L. Lynch, and M. D. Bennett. 2002. gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. Journal of Substance Abuse Treatment 23:285–95.
   PubMed Web of Science ®Google Scholar
• Greenfield, S. F., S. E. Back, K. Lawson, and K. T. Brady. 2010. Substance abuse in women. Psychiatric Clinics of North America 33:339–55. doi:10.1016/j.psc.2010.01.004.
   PubMed Web of Science ®Google Scholar
• Heatherton, T. F., L. T. Kozlowski, and R. C. Frecker. 1991. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. British Journal of Addiction 86:119–1127.
   Google Scholar
• Hudziak, J. J., J. E. Helzer, M. W. Wetzel, K. B. Kessel, B. McGee, A. Janca, and T. Przybeck. 1993. The use of the DSM-III-R checklist for initial diagnostic assessments. Comprehensive Psychiatry 34:375–83.
   PubMed Web of Science ®Google Scholar
• Jones, J. D., S. Mogali, and S. D. Comer. 2012. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence 125 (1–2):8–18. doi:10.1016/j.drugalcdep.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Kaiser Family Foundation. 2018. Opioid overdose deaths by gender. Accessed July 11, 2018. https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-gender.
   Google Scholar
• Kaye, A. D., M. R. Jones, A. M. Kaye, J. G. Ripoll, V. Galan, B. D. Beakley, F. Calixto, Urman RD, Manchikanti L. et al. 2017. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician 20 (2S):S93–S109.
   PubMed Web of Science ®Google Scholar
• Kelly, S. M., R. P. Schwartz, K. E. O. Grady, S. G. Mitchell, H. Schacht Reisinger, J. A. Peterson, M. H. Agar, and B. S. Brown. 2009. Gender differences among in- and out-of-treatment opioid-addicted individuals. American Journal of Drug and Alcohol Abuse 35 (1):38–42. doi:10.1080/00952990802342915.
   PubMed Web of Science ®Google Scholar
• Kroenke, K., R. Spitzer, and W. Williams. 2001. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 16:606–16.
   PubMed Web of Science ®Google Scholar
• Litt, M. D., R. M. Kadden, and H. Tennen. 2012. The nature of coping in treatment for marijuana dependence: latent structure and validation of the coping strategies scale. Psychology of Addictive Behaviors 26 (4):791.
   PubMed Web of Science ®Google Scholar
• Mannerfelt, C., and A. Håkansson. 2018. Substance use, criminal recidivism, and mortality in criminal justice clients: a comparison between men and women. Journal of Addiction 2018 (1689637):1–9. doi:10.1155/2018/1689637.
   Google Scholar
• McHugh, R. K., E. E. DeVito, D. Dodd, K. M. Carroll, J. S. Potter, S. F. Greenfield, H. Smith Connery, and R. D. Weiss. 2013. Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment 45 (1):38–43. doi:10.1016/j.jsat.2012.12.007.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., L. Luborsky, C. P. O’Brien, and G. E. Woody. 1980. An improved diagnostic instrument for substance abuse patients: the addiction severity index. Journal of Nervous & Mental Diseases 168 (1):26–33.
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering, and Medicine. 2017. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington, DC: The National Academies Press. doi:10.17226/24781.
   Google Scholar
• National Institute on Drug Abuse. 2018. Sex and gender differences in substance use. Accessed July 22, 2019. https://www.drugabuse.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use
   Google Scholar
• Palis, H., K. Marchand, D. Guh, S. Brissette, K. Lock, S. MacDonald, S. Harrison, Anis AH, Krausz M, Marsh DC, Schechter MT. et al. 2017. Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder. Substance Abuse Treatment, Prevention, and Policy 12 (1):25. doi:10.1186/s13011-017-0110-9.
   PubMed Web of Science ®Google Scholar
• Pinkhasov, R. M., J. Wong, J. Kashanian, M. Lee, D. B. Samadi, M. M. Pinkhasov, and R. Shabsigh. 2010. Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. International Journal of Clinical Practice 64:475–87. doi:10.1111/j.1742-1241.2009.02290.x.
   PubMed Web of Science ®Google Scholar
• Serdarevic, M., C. W. Striley, K. K. Gurka, R. F. Leeman, and L. B. Cottler. 2019. Sex differences in prescription opioid use patterns assessed through a community engagement program in Florida. Drug and Alcohol Dependence 204:1–10. doi:10.1016/j.drugalcdep.2019.107568.
   Web of Science ®Google Scholar
• Smith, K. Z., P. H. Smith, S. A. Cercone, S. A. McKee, and G. G. Homish. 2016. past year non-medical opioid use and abuse and PTSD diagnosis: interactions with sex and associations with symptom clusters. Addictive Behaviors 58:167–74. doi:10.1016/j.addbeh.2016.02.019.
   PubMed Web of Science ®Google Scholar
• Smith, P. H., K. A. Kasza, Ma, A. Hyland, G. T. Fong, R. Borland, K. Brady, M. J. Carpenter, K. Hartwell, K. M. Cummings, and S. A. Mckee. 2015. gender differences in medication use and cigarette smoking cessation: results from the international tobacco control four country survey. Nicotine & Tobacco Research 463–72. doi:10.1093/ntr/ntu212.
   PubMed Web of Science ®Google Scholar
• Sobell, L. C., and M. B. Sobel. 1992. Timeline follow-back: A technique for assessing self-reported alcohol consumption, in measuring alcohol consumption: psychosocial and biological methods. ed. J. Allen and R. Z. Litten, 41–72. Totowa, NJ: Humana Press.
   Google Scholar
• Spitzer, R. L., K. Kroenke, and J. B. Williams, Patient Health Questionnaire Primary Care Study Group. 1999. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 282(18):1737–44.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Office on Women’s Health. 2017. Final report: opioid use, misuse, and overdose in women.
   Google Scholar
• Weissman, M. M. 1999. Social adjustment scale-self report. North Tonawanda, NY: Multi Health Systems.
   Google Scholar